This invention is directed to 4-substituted 17.beta.-(cyclopropylamino)androst-5-en-3.beta.-ol and related compoundsand also to a method for using such compounds in thetreatment of androgen-dependent disorders. The compoundsare prepared by the hydride reduction of an appropriatesteroidal imine or enamine.
展开▼